0001209191-23-055560.txt : 20231116
0001209191-23-055560.hdr.sgml : 20231116
20231116173656
ACCESSION NUMBER: 0001209191-23-055560
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231115
FILED AS OF DATE: 20231116
DATE AS OF CHANGE: 20231116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cross Shawn
CENTRAL INDEX KEY: 0001734779
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39306
FILM NUMBER: 231415699
MAIL ADDRESS:
STREET 1: 1825 K STREET SUITE 510
CITY: WASHINGTON
STATE: DC
ZIP: 20006
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Applied Molecular Transport Inc.
CENTRAL INDEX KEY: 0001801777
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 814481426
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O THE CORPORATION TRUST COMPANY
STREET 2: CORPORATION TRUST CENTER, 1209 ORANGE ST
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 650-392-0420
MAIL ADDRESS:
STREET 1: C/O THE CORPORATION TRUST COMPANY
STREET 2: CORPORATION TRUST CENTER, 1209 ORANGE ST
CITY: WILMINGTON
STATE: DE
ZIP: 19801
FORMER COMPANY:
FORMER CONFORMED NAME: Applied Molecular Transport LLC
DATE OF NAME CHANGE: 20200130
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-15
0
0001801777
Applied Molecular Transport Inc.
AMTI
0001734779
Cross Shawn
C/O APPLIED MOLECULAR TRANSPORT INC.
1209 ORANGE ST
WILMINGTON
DE
19801
1
1
0
0
CEO & Chair of the Board
0
Common Stock
2023-11-15
4
S
0
90447
0.1606
D
656301
D
Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.15 to $0.1748, inclusive. The reporting person undertakes to provide Applied Molecular Transport, Inc., any security holder of Applied Molecular Transport, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
A portion of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
/s/ Brandon Hants attorney-in-fact for Shawn Cross
2023-11-16